Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche span> par promoteur : Eisai
Femme et Homme Max 99 ans
Eisai Limited
MAJ Il y a 5 ans
A Multi-centre, Randomised, Double-blind, Placebo- and Entacapone-controlled, Parallel Group Study of the Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients with Motor Fluctuations
To compare the efficacy of one dose strength (4 mg) of E2007 with that of placebo on motor function in patients with Parkinson's disease (PD) who are on optimised and stabilised therapy and experience...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme Max 99 ans
Eisai Limited
MAJ Il y a 5 ans
A phase II open label single-arm study of E7389 in patients with locally advanced or metastatic breast cancer, previously treated with anthracycline, taxane, and capecitabine therapy, refractory to the last prior therapy for their disease
To evaluate the efficacy and safety of E7389 in patients with locally advanced or metastatic breast cancer who have received anthracycline, taxane, and capecitabine as prior therapy, and are refractor...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eisai Ltd
MAJ Il y a 5 ans
A Phase 1b/2 trial studying how well lenvatinib works in treating children and adolescents with different types of cancer that are not responding to treatment or have reappeared following an initial recovery
Cohort 1 (Single-Agent Dose-Finding) Identify the recommended dose (RD) of lenvatinib as a single agent in children and adolescents with relapsed or refractory solid malignant tumors Cohort 2 (Sin...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations
Femme et Homme Max 99 ans
Eisai Limited
MAJ Il y a 5 ans
A randomized, multi-centre, double-blind study, to compare the efficacy and safety of zonisamide and carbamazepine as monotherapy, in newly diagnosed partial epilepsy
To assess the efficacy of zonisamide compared to carbamazepine when given as monotherapy to newly diagnosed subjects with partial seizures by assessment of 26 weeks seizure free rate.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Eisai Limited
MAJ Il y a 5 ans
A double-blind, randomised, placebo-controlled, multi-centre study to assess the efficacy and safety of adjunctive zonisamide in myoclonic seizures associated with idiopathic generalised epilepsy. Estudio en doble ciego, aleatorizado, controlado con placebo y multicéntrico, dirigido a evaluar la eficacia y la seguridad del tratamiento adyuvante con zonisomida en las crisis mioclónicas asociadas a la epilepsia generalizada idiopática
The objective of this trial is to assess the efficacy of adjunctive zonisamide in IGE in reducing the frequency of myoclonic seizures in subjects with continuing seizures despite treatment with one or...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eisai Ltd
MAJ Il y a 5 ans
A Randomized, Double-blind, Phase 2 Trial to assess how safe and how efficacious Lenvatinib is at two different starting doses (18 mg vs. 14 mg QD) when it is given in Combination with Everolimus (5 mg once a day ) in patients with Renal cancer that have already had one VEGF-Targeted Treatment Ensayo de fase 2, aleatorizado y doble ciego para evaluar la seguridad y la eficacia de lenvatinib en dos dosis iniciales diferentes (18 mg y 14 mg una vez al día) cuando se administra en combinación con everolimus (5 mg una vez al día) en pacientes con cáncer renal después de un tratamiento previo dirigido contra el VEGF
To assess whether a starting dose of lenvatinib 14 mg in combination with everolimus 5 mg once daily (QD) will provide comparable efficacy (based on objective response rate [ORR]at 24 weeks[ORR24W]) w...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eisai Limited
MAJ Il y a 5 ans
A Study on the Effect of E5501 (study drug) in Adults with Chronic Immune Thrombocytopenia
Core Study To demonstrate that the efficacy of E5501 (in addition to standard of care) is superior to placebo (in addition to standard of care) for the treatment of adult subjects with chronic immune...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eisai Limited
MAJ Il y a 5 ans
Phase II, Multicenter, Open-label, Single Arm Trial to Evaluate the Safety and Efficacy of Oral E7080 in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology
In patients with medullary thyroid cancer [MTC] or radioiodine (131I) refractory/resistant differentiated thyroid cancer[DTC]: Determine the effect of E7080 on the objective response rate (ORR) bas...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eisai Limited
MAJ Il y a 5 ans
Open Label Extension Study Following Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess Efficacy and Safety of Adjunctive Zonisamide in Primary Generalized Tonic-Clonic Seizures
The objective of this study is to assess the long-term safety of zonisamide in subjects with primary generalized tonic-clonic seizures (PGTCS).
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme
Entre 18 ans
et 99 ans
Eisai Medical Research Inc.
MAJ Il y a 5 ans
Eisai E7389-G000-301 : Essai de phase 3 randomisé comparant l’efficacité de 2 chimiotérapies par eribulin ou par capécitabine chez des patientes ayant un cancer du sein. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
l'objectif de cet essai est de comparer l'efficacité de 2 chimiotérapies par eribulin ou par capécitabine chez des patientes ayant un cancer du sein.
Pays
France
Organes
Sein
Spécialités
Chimiothérapie
Essai clos aux inclusions
Plus d'informations
Précédent
1
2
3
4
5
6
7
8
9
Suivant